Phamacodynamic and circulating tumor DNA evaluation in a phase I study of GDC-0927, a selective estrogen receptor antagonist/degrader (SERD) - Spoerke, J M; Spoerke, J M; Daemen, A; Daemen, A; Chang, C-W; Giltnane, J; Giltnane, J; Metcalfe, C; Metcalfe, C; Dickler, M N; Dickler, M N; Bardia, A; et al. (Cancer Research, 2019)